|
J Biol Chem, Vol. 274, Issue 10, 6039-6042, March 5, 1999
COMMUNICATION
Long Term Lithium Treatment Suppresses p53 and Bax Expression but
Increases Bcl-2 Expression
A PROMINENT ROLE IN NEUROPROTECTION AGAINST EXCITOTOXICITY
Ren-Wu
Chen and
De-Maw
Chuang
From the Section on Molecular Neurobiology, Biological Psychiatry
Branch, National Institute of Mental Health,
Bethesda, Maryland 20892-1272
This study was undertaken to investigate the
molecular mechanisms underlying the neuroprotective actions of lithium
against glutamate excitotoxicity with a focus on the role of
proapoptotic and antiapoptotic genes. Long term, but not acute,
treatment of cultured cerebellar granule cells with LiCl induces a
concentration-dependent decrease in mRNA and protein
levels of proapoptotic p53 and Bax; conversely, mRNA and protein
levels of cytoprotective Bcl-2 are remarkably increased. The ratios of
Bcl-2/Bax protein levels increase by approximately 5-fold after lithium
treatment for 5-7 days. Exposure of cerebellar granule cells to
glutamate induces a rapid increase in p53 and Bax mRNA and protein
levels with no apparent effect on Bcl-2 expression. Pretreatment
with LiCl for 7 days prevents glutamate-induced increase in p53 and Bax
expression and maintains Bcl-2 in an elevated state. Glutamate exposure
also triggers the release of cytochrome c from the
mitochondria into the cytosol. Lithium pretreatment blocks
glutamate-induced cytochrome c release and cleavage of
lamin B1, a nuclear substrate for caspase-3. These results strongly
suggest that lithium-induced Bcl-2 up-regulation and p53 and Bax
down-regulation play a prominent role in neuroprotection against
excitotoxicity. Our results further suggest that lithium, in addition
to its use in the treatment of bipolar depressive illness, may have an
expanded use in the intervention of neurodegeneration.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Leng, M.-H. Liang, M. Ren, Z. Marinova, P. Leeds, and D.-M. Chuang
Synergistic Neuroprotective Effects of Lithium and Valproic Acid or Other Histone Deacetylase Inhibitors in Neurons: Roles of Glycogen Synthase Kinase-3 Inhibition
J. Neurosci.,
March 5, 2008;
28(10):
2576 - 2588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. McColl, D. W. Killilea, A. E. Hubbard, M. C. Vantipalli, S. Melov, and G. J. Lithgow
Pharmacogenetic Analysis of Lithium-induced Delayed Aging in Caenorhabditis elegans
J. Biol. Chem.,
January 4, 2008;
283(1):
350 - 357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mazza, M. Di Nicola, G. D. Marca, L. Janiri, P. Bria, and S. Mazza
Bipolar Disorder and Epilepsy: A Bidirectional Relation? Neurobiological Underpinnings, Current Hypotheses, and Future Research Directions
Neuroscientist,
August 1, 2007;
13(4):
392 - 404.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Rockenstein, M. Torrance, A. Adame, M. Mante, P. Bar-on, J. B. Rose, L. Crews, and E. Masliah
Neuroprotective Effects of Regulators of the Glycogen Synthase Kinase-3{beta} Signaling Pathway in a Transgenic Model of Alzheimer's Disease Are Associated with Reduced Amyloid Precursor Protein Phosphorylation
J. Neurosci.,
February 21, 2007;
27(8):
1981 - 1991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Yazlovitskaya, E. Edwards, D. Thotala, A. Fu, K. L. Osusky, W. O. Whetsell Jr., B. Boone, E. T. Shinohara, and D. E. Hallahan
Lithium Treatment Prevents Neurocognitive Deficit Resulting from Cranial Irradiation
Cancer Res.,
December 1, 2006;
66(23):
11179 - 11186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Williams, C. C. Bautista, R.-W. Chen, J. R. Dave, X.-C. M. Lu, F. C. Tortella, and J. A. Hartings
Evaluation of Gabapentin and Ethosuximide for Treatment of Acute Nonconvulsive Seizures following Ischemic Brain Injury in Rats
J. Pharmacol. Exp. Ther.,
September 1, 2006;
318(3):
947 - 955.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-L. Chen, C.-F. Lin, C.-W. Chiang, M.-S. Jan, and Y.-S. Lin
Lithium Inhibits Ceramide- and Etoposide-Induced Protein Phosphatase 2A Methylation, Bcl-2 Dephosphorylation, Caspase-2 Activation, and Apoptosis
Mol. Pharmacol.,
August 1, 2006;
70(2):
510 - 517.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Sinha, Z. Wang, K. L. Ruchalski, J. S. Levine, S. Krishnan, W. Lieberthal, J. H. Schwartz, and S. C. Borkan
Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors
Am J Physiol Renal Physiol,
April 1, 2005;
288(4):
F703 - F713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Annunziato, G. Pignataro, and G. F. Di Renzo
Pharmacology of Brain Na+/Ca2+ Exchanger: From Molecular Biology to Therapeutic Perspectives
Pharmacol. Rev.,
December 1, 2004;
56(4):
633 - 654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Wood, L. T. Young, L. P. Reagan, B. Chen, and B. S. McEwen
Stress-induced structural remodeling in hippocampus: Prevention by lithium treatment
PNAS,
March 16, 2004;
101(11):
3973 - 3978.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Hongisto, N. Smeds, S. Brecht, T. Herdegen, M. J. Courtney, and E. T. Coffey
Lithium Blocks the c-Jun Stress Response and Protects Neurons via Its Action on Glycogen Synthase Kinase 3
Mol. Cell. Biol.,
September 1, 2003;
23(17):
6027 - 6036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ren, V. V. Senatorov, R.-W. Chen, and D.-M. Chuang
Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model
PNAS,
May 13, 2003;
100(10):
6210 - 6215.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Huang, D.-Y. Wu, G. Chen, H. Manji, and D. F. Chen
Support of Retinal Ganglion Cell Survival and Axon Regeneration by Lithium through a Bcl-2-Dependent Mechanism
Invest. Ophthalmol. Vis. Sci.,
January 1, 2003;
44(1):
347 - 354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Carmichael, K. L. Sugars, Y. P. Bao, and D. C. Rubinsztein
Glycogen Synthase Kinase-3beta Inhibitors Prevent Cellular Polyglutamine Toxicity Caused by the Huntington's Disease Mutation
J. Biol. Chem.,
September 6, 2002;
277(37):
33791 - 33798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.-C. Kim, H.-T. Kim, M. Mamura, I. S. Ambudkar, K.-S. Choi, and S.-J. Kim
Tumor Necrosis Factor Induces Apoptosis in Hepatoma Cells by Increasing Ca2+ Release from the Endoplasmic Reticulum and Suppressing Bcl-2 Expression
J. Biol. Chem.,
August 23, 2002;
277(35):
31381 - 31389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. I. Rapoport and F. Bosetti
Do Lithium and Anticonvulsants Target the Brain Arachidonic Acid Cascade in Bipolar Disorder?
Arch Gen Psychiatry,
July 1, 2002;
59(7):
592 - 596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Watcharasit, G. N. Bijur, J. W. Zmijewski, L. Song, A. Zmijewska, X. Chen, G. V. W. Johnson, and R. S. Jope
Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage
PNAS,
June 11, 2002;
99(12):
7951 - 7955.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Rossig, C. Badorff, Y. Holzmann, A. M. Zeiher, and S. Dimmeler
Glycogen Synthase Kinase-3 Couples AKT-dependent Signaling to the Regulation of p21Cip1 Degradation
J. Biol. Chem.,
March 15, 2002;
277(12):
9684 - 9689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Gold and P. D. Thut
Lithium Increases Potency of Lidocaine-Induced Block of Voltage-Gated Na+ Currents in Rat Sensory Neurons in Vitro
J. Pharmacol. Exp. Ther.,
November 1, 2001;
299(2):
705 - 711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. N. Bijur, P. De Sarno, and R. S. Jope
Glycogen Synthase Kinase-3beta Facilitates Staurosporine- and Heat Shock-induced Apoptosis. PROTECTION BY LITHIUM
J. Biol. Chem.,
March 10, 2000;
275(11):
7583 - 7590.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. C. Ikonomov and H. K. Manji
Molecular Mechanisms Underlying Mood Stabilization in Manic-Depressive Illness: The Phenotype Challenge
Am J Psychiatry,
October 1, 1999;
156(10):
1506 - 1514.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. Chalecka-Franaszek and D.-M. Chuang
Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons
PNAS,
July 20, 1999;
96(15):
8745 - 8750.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. DeGregorio-Rocasolano, T. Gasull, and R. Trullas
Overexpression of Neuronal Pentraxin 1 Is Involved in Neuronal Death Evoked by Low K+ in Cerebellar Granule Cells
J. Biol. Chem.,
January 5, 2001;
276(1):
796 - 803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lakkaraju, J. M. Dubinsky, W. C. Low, and Y.-E. Rahman
Neurons Are Protected from Excitotoxic Death by p53 Antisense Oligonucleotides Delivered in Anionic Liposomes
J. Biol. Chem.,
August 17, 2001;
276(34):
32000 - 32007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Mao, P. Hoang, and P. E. DiCorleto
Lithium Inhibits Cell Cycle Progression and Induces Stabilization of p53 in Bovine Aortic Endothelial Cells
J. Biol. Chem.,
July 6, 2001;
276(28):
26180 - 26188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Rossig, C. Badorff, Y. Holzmann, A. M. Zeiher, and S. Dimmeler
Glycogen Synthase Kinase-3 Couples AKT-dependent Signaling to the Regulation of p21Cip1 Degradation
J. Biol. Chem.,
March 15, 2002;
277(12):
9684 - 9689.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|